I'm LongbridgeAI, I can summarize articles.VIXY.US rose 1.76% this week to close at $17.30, outperforming the S&P 500 by about 2.56 percentage points; the benchmark fell 0.8%. The pattern was a rally followed by a pullback: Tuesday (8 Sep) opened at $17.00 and touched $18.00 intraday; Wednesday and Thursday pushed higher, with Thursday reaching $18.205 and closing at $18.16; Friday opened lower and slid to $16.81 before settling back at $17.30. Full-week amplitude was 8.21%, and average daily volume of 2.
The Week
VIXY.US rose 1.76% this week to close at $17.30, outperforming the S&P 500 by about 2.56 percentage points; the benchmark fell 0.8%. The pattern was a rally followed by a pullback: Tuesday (8 Sep) opened at $17.00 and touched $18.00 intraday; Wednesday and Thursday pushed higher, with Thursday reaching $18.205 and closing at $18.16; Friday opened lower and slid to $16.81 before settling back at $17.30. Full-week amplitude was 8.21%, and average daily volume of 2.71m shares ran about 17.17% above the median.
Cboe Volatility Index This Week
The Cboe Volatility Index rose 9.02% this week to close at 15.84, with amplitude widening to 18.96%. It opened at 15.56 on Tuesday, climbed to 16.46 by Wednesday, spiked to 18.17 on Thursday before closing at 17.84, then fell back to 15.84 on Friday. Within the 60-day range—high of 20.88 and low of 13.80—the index sits above its 20-day average of 15.396 but below the 60-day average of 16.435.
Leverage & Decay
This product tracks the daily move of the Cboe Volatility Index, not the weekly cumulative move. The underlying rose 9.02% this week, implying a theoretical 1x gain of about +9.02%, but VIXY.US returned only +1.76%, a gap of 7.26 percentage points. The drag comes from daily rebalancing: the fund resets exposure to its target multiple every day, so in a choppy tape where one day’s gain is partly reversed the next, the compounding path diverges from a straight-line extension. This week’s late-session round trip in the underlying ate into the product’s return, and holding over a full week does not simply equal 1x the index’s weekly change.
Cboe Volatility Index News
Two threads ran through the week’s news. The first was Fed rate expectations: early in the week Trump called for sharp cuts, employment data then revived hike talk, and after the 12 Sep CPI print the market-implied probability of a hike jumped to nearly 90%, keeping volatility on edge. The second was the market’s own read on vol: 7 Sep items flagged a bounce window, and by 11 Sep several pieces discussed the VIX heading toward 25, with oil prices and yields forming a risk cluster—even as Wall Street rallied on the firm inflation data. These discussions coincided with the VIX’s rise-and-fade pattern; they are correlations rather than a causal chain.
The Week Ahead
The focus next week is the Fed’s FOMC decision on 16 Sep, preceded by the New York Fed manufacturing index on 15 Sep and followed on 16 Sep by retail sales, import prices, the NAHB housing index, and EIA crude stockpiles. For VIXY.US the key is whether the Cboe Volatility Index keeps expanding around the rate decision: with hike odds near 90% after the CPI print, a continuation of this week’s rise-and-fade could push short-term vol higher.
In Short
VIXY.US moved in the same direction as the underlying but by a much smaller amount: the index gained 9.02% while the product added 1.76%, the gap coming from daily rebalancing. Against a 0.8% drop in the S&P 500, the product held up relatively well. Sentiment-wise, the hotter CPI raised hike odds and briefly lifted the VIX before it faded, leaving the market torn between expectations of higher vol and a rebound in equities. Technically, the product still trades below its 20-day average of 17.85 and 60-day average of 19.945, in the lower half of its 60-day range. The next test is whether vol keeps expanding or quickly normalises after the FOMC, and whether the VIX can clear this week’s high of 18.17 or drift toward the 25 area discussed in market commentary.
This article is generated by LongbridgeAI from market data, for information only and not investment advice.
